DrugPatentWatch Database Preview
Drugs in Development Information for Oteracil
Development status for investigational drug Oteracil: Patents, clinical trial progress, indications
Oteracil is an investigational drug.
There have been 64 clinical trials for Oteracil.
The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2016.
The most common disease conditions in clinical trials are Stomach Neoplasms, Pancreatic Neoplasms, and Head and Neck Neoplasms. The leading clinical trial sponsors are Fudan University, Taiho Oncology, Inc., and Quintiles, Inc.
There are eighty-six US patents protecting this investigational drug and eight hundred and eighteen international patents.
Summary for Oteracil
| US Patents | 86 |
| International Patents | 818 |
| US Patent Applications | 128 |
| WIPO Patent Applications | 80 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2016-09-01) |
| Vendors | 27 |
Recent Clinical Trials for Oteracil
| Title | Sponsor | Phase |
|---|---|---|
| SOX-based CRT for Esophageal Cancer. | Zhejiang Provincial People’s Hospital | Phase 1/Phase 2 |
| S-1 for 9 Months Versus 1 Year for Gastric Cancer Staged II（SMAC） | Fudan University | Phase 2 |
| Tegio Consolidation Therapy for NPC Patients With High Risk of Metastasis | Zhejiang Cancer Hospital | Phase 2 |
Clinical Trial Summary for Oteracil
Top disease conditions for Oteracil
Top clinical trial sponsors for Oteracil
US Patents for Oteracil
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Oteracil | Start Trial | Chromane herbicides | E. I. Du Pont de Nemours and Company (Wilmington, DE) | Start Trial |
| Oteracil | Start Trial | Composition and method for inhibiting inflammation caused by non-parenteral administration of 5-fluorouracil type compounds | Otsuka Pharmaceutical Co., Ltd. (Tokyo, JP) | Start Trial |
| Oteracil | Start Trial | Salts of optically active 4-hydroxy-8(3-lower alkoxy-4-phenylsulfinylphenyl)pyrazolo(1,5-A)-1,3,5- triazines and a process for production thereof | Otsuka Pharmaceutical Factory, Inc. (Tokushima, JP) | Start Trial |
| Oteracil | Start Trial | Prodrugs for selective drug delivery | Start Trial | |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Oteracil
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Oteracil | Argentina | 243522 | 2006-12-10 | Start Trial |
| Oteracil | Australia | 8215287 | 2006-12-10 | Start Trial |
| Oteracil | Brazil | 8706588 | 2006-12-10 | Start Trial |
| Oteracil | China | 1021824 | 2006-12-10 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
